Jack Eades, MD
Allergy & Immunology · Macon, GANPI 1992890727
Payments from drug & device makers
Across 809 payments — averaging $348.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$202K
- AstraZeneca$45K
- Novartis$14K
- Pfizer$7K
- Chiesi USA, Inc.$3K
- CSL Behring$3K
- plus $7K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 259 | $202,090 |
| AstraZeneca | 81 | $45,147 |
| Novartis | 10 | $14,356 |
| Pfizer | 71 | $6,657 |
| Chiesi USA, Inc. | 4 | $3,400 |
| CSL Behring | 132 | $2,864 |
| GSK | 31 | $2,703 |
| Regeneron Healthcare Solutions, Inc. | 29 | $685 |
| Octapharma USA, Inc. | 12 | $656 |
| Biocryst US Sales Co., LLC | 22 | $577 |
| Genentech USA, Inc. | 15 | $388 |
| Kaleo, Inc. | 16 | $281 |
| Teva Pharmaceuticals USA, Inc. | 36 | $275 |
| Amgen(2 entities) | 12 | $237 |
| Optinose US, Inc. | 11 | $214 |
| AbbVie | 5 | $201 |
| Sanofi | 9 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $181 |
| Grifols USA, LLC | 8 | $128 |
| Merck | 10 | $112 |
| Hikma Pharmaceuticals USA | 5 | $95 |
| Eyevance Pharmaceuticals LLC | 3 | $59 |
| Hospira, Inc. | 3 | $58 |
| Incyte Corporation | 1 | $57 |
| Phadia US Inc. | 3 | $57 |
| Covis Pharma GmbH | 2 | $49 |
| Boehringer Ingelheim | 2 | $39 |
| Circassia Inc. | 2 | $36 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Aimmune Therapeutics, Inc. | 2 | $27 |
| ADMA Biomanufacturing LLC | 1 | $25 |
| Regeneron | 1 | $24 |
| Shire North American Group Inc | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Jubilant Hollisterstier LLC | 1 | $18 |
How this compares
$281,987 in reported general payments places this provider in the 90th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Macon
- Jeffrey LangfordMacon$13K
- Nathan SegallStockbridge$4.5M
- Tracy BridgesAlbany$1.5M
- Brad GoodmanSavannah$1.3M
- Michael BlaissRoswell$1.1M
- Robert ChrzanowskiColumbus$941K
- Stanley FinemanMarietta$855K
- Robert CartwrightColumbus$678K
- Deborah BirxAtlanta$470K
- Bruce FinkelSavannah$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.